Variance 'Extraction' [General Sta­tis­tics]

posted by atish_azad – 2008-06-28 09:01 (5868 d 19:53 ago) – Posting: # 1980
Views: 6,348

Dear HS,

This is a pilot three squence, three period crossover study.

1. Ratio for T2/R is around 98.63% and for T1/R is around 50.00%. I guess Variance is too high Which has affected 90% CI for T2/R to go out of Bioequivalence limit.
2. Calculated sample size for ratio T2/R and Using common variance is too high (more than 100).
3. When I did the analysis by blocking T1 from pharmacokinetic output of WinNonlin ratio of T2/R is around 105.00% and CI fall within bioequivalence limit and intraCV is around 27.99% (calculated from variance).
4. Calculated sample size for ratio T2/R and Using variance (intra CV of 27.99%) is around 33.
5. By blocking T1, ANOVA table shows two degree of freedom for Sequence and Period, since there are 3 Sequence and 3 Period.
6. Is my analysis by blocking T1 is correct?
7. Can I use sample size of 36 if a pivotal study is planned for T2 and R?

Regards,

Atish

Complete thread:

UA Flag
Activity
 Admin contact
23,113 posts in 4,858 threads, 1,644 registered users;
41 visitors (0 registered, 41 guests [including 12 identified bots]).
Forum time: 04:54 CEST (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5